Skip to main content

Advertisement

Table 1 Model parameter values

From: Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything

Variable Age group Value (range) Source
Population size 0-2 63,025 2006 Census [42]
  3-4 42,260  
  5-17 322,670  
  18-24 203,500  
  25-54 975,875  
  55-64 237,795  
  ≥65 271,455  
  Total 2,116,580  
Latent period (days) All 3 (2-4) Tuite et al. 2010 [22]
Initial asymptomatic infectious period (in all infected individuals) (days) All 1 Liao et al. 2010 [43]
Total duration of infectiousness (days) All 7 (5-7) Tuite et al. 2010 [22]; De Serres [44]
Basic Reproduction number (R 0) All 1.4 (1.2-1.8) Pourbohloul et al. 2009 [27]
Proportion of population with pre-existing immunity ≥55 0.5 Centers for Disease Control and Prevention 2009 [13]; Fisman et al. 2009 [6]
Vaccine efficacy All 0.9 (0.5-1) Product Monograph Arepanrix(tm) H1N1 [45]; Waddington et al., 2010 [46]
Proportion of infected individuals who self-isolate All 0.1 (0.1-0.6) Assumption
Mortality (per 100,000 infections) 0-2 30 Donaldson et al. 2009 [47]
  2-4 27  
  5-17 11  
  18-24 12  
  25-54 30  
  55-64 65  
  ≥65 980